STK11 mutation is known to induce p21 expression predominantly in lung adenocarcinoma, [24] and our observation from the western blot analysis indicate high levels of p21 expression in 10/11 (91%) cTCL tumors (Figure 3A). Here, STK11 is linked to lung adenocarcinoma.